The MEK inhibitors: trametinib and selumetinib

Update: 2021-02-19

Description

The MEK inhibitors are a newer class of drug, and include trametinib, selumetinib and others. They have an important role in paediatric oncology, particularly in glioma treatment and in neurofibromatosis.

Hosted on Acast. See acast.com/privacy for more information.

Comments

In Channel

CAR T-cells, Interview with Dr Caroline Bateman

2022-03-1445:55

"S" is for "Special" : Stage MS Neuroblastoma (also called Stage IVS, 4S)

2021-05-2024:26

Where did my child's immune system go?

2021-03-2644:44

Update re the future of rock and roll.... CAR T-cells

2021-03-1039:46

Blood Cultures

2021-03-0822:13

PRISM, Molecular Profiling, and Informed Consent

2021-02-2456:12

The MEK inhibitors: trametinib and selumetinib

2021-02-1941:14

The needle in the haystack: Minimal Residual Disease

2021-01-1442:05

DIPG: to biopsy or not to biopsy

2020-11-1613:37

DIPG: what do these letters stand for?

2017-01-2219:55

Chemotherapy 7: Ifosfamide

2016-11-2722:51

Why does my child need a heart test? Echo's and ECG's.

2016-09-0716:42

Highlights of ASCO: Two transplants for neuroblastoma??

2016-08-0830:12

"A Selfless Act": my reading of an article on clinical trials in childhood cancer.

2016-05-2517:52

Residents, fellows, registrars; who are all these doctors?

2016-05-2331:49

G-CSF and PEG G-CSF: drugs to boost the bone marrow.

2016-04-1327:53

Neuroblastoma 3: High-dose MIBG as treatment

2016-04-0627:17

Adolescents and Young Adults with Cancer: What's special about the AYA's?

2016-03-2125:33

Neuroblastoma 2: MIBG scans

2016-01-0520:08

What not to give your oncologist for Christmas.

2015-12-1632:45

00:00

1.0x

The MEK inhibitors: trametinib and selumetinib

#box-pro-ellipsis-175978241219055{-webkit-line-clamp:2;}The MEK inhibitors: trametinib and selumetinib

The MEK inhibitors: trametinib and selumetinib

The MEK inhibitors: trametinib and selumetinib